First-trimester drug use and congenital disorders

Obstet Gynecol. 1985 Apr;65(4):451-5.

Abstract

The authors determined the prevalence of certain major congenital disorders among live-born infants of 6509 mothers in a prepaid health plan for the 30-month period of January 1, 1980 through June 30, 1982 who used a wide variety of drugs during the first trimester of pregnancy. The results were similar to those obtained in this population in a prior 30-month study. No strong associations between any of the commonly used drugs and the congenital disorders studied were present.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Abnormalities, Drug-Induced / epidemiology
  • Abnormalities, Drug-Induced / etiology*
  • Brompheniramine / adverse effects
  • Congenital Abnormalities / epidemiology*
  • Congenital Abnormalities / etiology
  • Dicyclomine
  • Doxylamine / adverse effects
  • Drug Combinations / adverse effects
  • Drug-Related Side Effects and Adverse Reactions*
  • Female
  • Humans
  • Infant, Newborn
  • Phenylephrine / adverse effects
  • Phenylpropanolamine / adverse effects
  • Pregnancy
  • Pregnancy Trimester, First*
  • Pseudoephedrine
  • Pyridoxine / adverse effects
  • Washington

Substances

  • Drug Combinations
  • brompheniramine, pseudoephedrine drug combination
  • dicyclomine, doxylamine, pyridoxine drug combination
  • Phenylephrine
  • Phenylpropanolamine
  • Dicyclomine
  • Pseudoephedrine
  • Doxylamine
  • Brompheniramine
  • Pyridoxine